In Vitro Diagnostics Market, Industry Trends and Global Forecasts, till 2035

In Vitro Diagnostics Market, Industry Trends and Global Forecasts, till 2035

The In Vitro Diagnostics Market is valued at USD 108 billion in 2024 growing at a CAGR of 5.2% during the forecast period 2024-2035.

In vitro diagnostic tests (IVD) are laboratory tests that examine human samples, such as blood or tissue, outside the human body. The term ""in vitro"" comes from Latin, meaning ""within the glass,"" which refers to the testing of biological samples in a controlled environment. These tests play a crucial role in diagnosing diseases, monitoring treatment progress, and predicting healthcare outcomes. IVD products are used in both industrial and clinical settings, and despite being non-invasive, they are subject to the same regulatory requirements as medical devices.

The in vitro diagnostic industry offers a wide range of products, from simple self-test glucose monitoring devices to complex laboratory procedures. These tests can identify blood types, diagnose cancer, and profile kidney function, among other applications. According to the World Health Organization, there are over 40,000 IVD products available in the market, highlighting the importance of diagnostics in healthcare.

In fact, over 70% of healthcare decisions are based on laboratory test results, underscoring the critical role of IVD products in patient care. Given the benefits of rapid diagnostic results and improved patient outcomes, the global in vitro diagnostics market is expected to grow at a healthy rate over the forecast period. The growth of the IVD market can be attributed to factors such as increasing demand for point-of-care diagnostics devices, rapid testing, and the growing prevalence of chronic diseases.



Key Market Segments

Test Type

• Laboratory Testing
• Point-of-Care Testing

Type of Offering

• Reagents
• Instruments
• Services

Type of Technology

• Clinical Chemistry
• Hematology
• Immunoassay
• Molecular Diagnostics
• Others

Therapeutic Area

• Autoimmune Diseases
• Cardiovascular Disorders
• Diabetes
• Infectious Diseases
• Renal Disorders
• Oncological Disorders
• Others

End Users

• Hospitals
• Laboratories
• Others

Key Geographical Regions

• North America (US, Canada)
• Europe (Austria, Belgium, France, Germany, Italy, Netherlands, Spain,

Switzerland, UK, Rest of the Europe)

• Asia (China, India, Indonesia, Japan, Singapore, South Korea, Thailand,

Rest of Asia)

• Latin America (Argentina, Brazil, Mexico, Rest of Latin America)
• Middle East and North Africa (Egypt, Israel, Saudi Arabia, Rest of Middle

East and North Africa)

• Rest of the World

Research Coverage:

• This chapter provides an overview of key concepts in the field of in vitro diagnostics, including the classification of in vitro diagnostic products, the therapeutic areas they target, and the various types of in vitro diagnostic tests. It also highlights the challenges faced in the in vitro diagnostics domain and presents recent advancements in this market space.
• This chapter provides an overview of the leading players in the in vitro diagnostics (IVD) market. The analysis includes information on their year of establishment, company size, location of headquarters and annual revenues of the players (FY23, USD billion). Further, it highlights a detailed assessment of the in vitro diagnostic solutions based on several relevant parameters, such as type of technology used (clinical chemistry, hematology, immunoassay, molecular diagnostics, urinalysis), diagnostic applications (autoimmune, cardiology, diabetes, gynecology, healthcare-associated infections, infectious diseases, oncological disorders, renal, sexually transmitted infections / diseases).
• This analysis evaluates the top players in the in vitro diagnostics market, considering factors such as years of experience, company competitiveness, and technological capabilities. It provides insights into their strengths and weaknesses.
• Comprehensive company profiles of leading IVD market players are provided, featuring detailed information on each company's background, financial performance, product offerings, and recent developments. This includes a brief overview, financial information, in vitro diagnostic products and services, recent developments, and expert analysis and future outlook for each company.
• Profiles of prominent IVD players are presented, highlighting key company details, financial performance, and product offerings. Each profile includes a brief overview, including year of establishment, number of employees, headquarters location, and executive team members. Additionally, financial information, in vitro diagnostic products and services, recent developments, and expert analysis of future outlook are provided for each company.
• A comprehensive Porter's Five Forces analysis is conducted, examining the competitive forces driving the global IVD market. The report assesses the threat of new entrants, bargaining power of buyers and suppliers, threats of substitute products, and rivalry among existing competitors to provide a detailed understanding of the market's dynamics.
• The report analyzes the factors influencing the growth of the IVD market, including key drivers, restraints, emerging opportunities, and existing challenges. It identifies and examines the impact of these factors on the market's dynamics, providing a comprehensive understanding of the industry's growth prospects.
• The report provides a comprehensive estimate of the current IVD market size, opportunity, and future growth potential from 2024 to 2035. Our analysis is based on multiple parameters, adoption trends, and primary validations. We have provided an informed estimate of market evolution, including the likely distribution of current and forecasted opportunity. To account for future uncertainties, we have also presented three forecast scenarios: conservative, base, and optimistic, representing different tracks of the industry's growth. This detailed analysis helps stakeholders understand the market's trajectory and make informed decisions.
• Comprehensive projection of the current and future in IVD market across different test types, such as laboratory testing and point-of-care testing.
• Detailed predictions of the current and future in vitro diagnostics market across different types of technologies, such as clinical chemistry, hematology, immunoassay, molecular diagnostics, and others.
• Comprehensive projections of the current and future in vitro diagnostic industry across different therapeutic areas, such as autoimmune diseases, cardiological disorders, diabetes, infectious diseases, renal disorders, oncological disorders, and others.
• Detailed predictions of the current and future in vitro diagnostics market across different end users, such as hospitals, laboratories and others.
• Detailed projection of the current and future in vitro diagnostic industry across key geographical regions, such as North America, Europe, Asia, Latin America, Middle East and North Africa and Rest of the World.

Key Benefits of Buying this Report

• The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
• Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
• The report provides stakeholders with a pulse on the In Vitro Diagnostics Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Leading Market Companies

• Abbott Laboratories
• Agilent
• Becton Dickinson
• bioMérieux
• Bio-Rad
• Danaher Corporation
• DiaSorin
• Exact Sciences
• Fujifilm
• Gold Standard Diagnostics
• Grifols
• Hologic
• Illumina
• LabCorp
• Qiagen
• Quest Diagnostics
• QuidelOrtho
• Roche
• Siemens Healthineers
• Sysmex
• Thermo Fisher Scientific
• Werfen